Evidence map›Paper›PMID 29652806›Full record

ReviewInternational journal of molecular sciences2018

Excessive Extracellular ATP Desensitizes P2Y2 and P2X4 ATP Receptors Provoking Surfactant Impairment Ending in Ventilation-Induced Lung Injury.

Djo Hasan, Joshua Satalin, Philip van der Zee, Michaela Kollisch-Singule, Paul Blankman, Atsuko Shono, Peter Somhorst, Corstiaan den Uil, Han Meeder, Toru Kotani and 1 more

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Targeting P2X Receptors-Current Progress in Sepsis.International journal of inflammation · 2025
    Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Role of the Purinergic P2Y2 Receptor in Pulmonary Hypertension.International journal of environmental research and public health · 2021
    Review
  9. Article
  10. Article
  11. Review
  12. P2 Purinergic Signaling in the Distal Lung in Health and Disease.International journal of molecular sciences · 2020
    Review
  13. Article
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Djo HasanMobile Intensive Care Unit Zuid-West Nederland, 3062 NW Rotterdam, The Netherlands. djohasan@gmail.com.
Joshua SatalinDepartment of Surgery, Upstate Medical University, Syracuse, NY 13210, USA. satalinj@upstate.edu.
Philip van der ZeeAdult Intensive Care Unit, Erasmus MC, Erasmus Universiteit Rotterdam, 3015 CE Rotterdam, The Netherlands. p.vanderzee@erasmusmc.nl.ORCID 0000-0002-5577-6848
Michaela Kollisch-SinguleDepartment of Surgery, Upstate Medical University, Syracuse, NY 13210, USA. kolliscm@upstate.edu.
Paul BlankmanDepartment of Anesthesiology, Universitair Medisch Centrum Utrecht, 3584 CX Utrecht, The Netherlands. p.blankman@umcutrecht.nl.
Atsuko ShonoDepartment of Anesthesiology, Shimane University, Izumo, Shimane Prefecture 693-0021, Japan. atsukos@med.shimane-u.ac.jp.ORCID 0000-0003-1383-3637
Peter SomhorstAdult Intensive Care Unit, Erasmus MC, Erasmus Universiteit Rotterdam, 3015 CE Rotterdam, The Netherlands. p.somhorst@erasmusmc.nl.
Corstiaan den UilAdult Intensive Care Unit, Erasmus MC, Erasmus Universiteit Rotterdam, 3015 CE Rotterdam, The Netherlands. c.denuil@erasmusmc.nl.
Han MeederMobile Intensive Care Unit Zuid-West Nederland, 3062 NW Rotterdam, The Netherlands. jmeeder@chello.nl.
Toru KotaniDepartment of Anesthesiology and Critical Care Medicine, Showa University, School of Medicine, Tokyo 142-8666, Japan. trkotani@med.showa-u.ac.jp.ORCID 0000-0001-9504-0061
Gary F NiemanDepartment of Surgery, Upstate Medical University, Syracuse, NY 13210, USA. niemang@upstate.edu.
Erasmus MC · NLSUNY Upstate Medical University · USShimane University · JPShowa University · JPUniversity Medical Center Utrecht · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stretching the alveolar epithelial type I (AT I) cells controls the intercellular signaling for the exocytosis of surfactant by the AT II cells through the extracellular release of adenosine triphosphate (ATP) (purinergic signaling). Extracellular ATP is cleared by extracellular ATPases, maintaining its homeostasis and enabling the lung to adapt the exocytosis of surfactant to the demand. Vigorous deformation of the AT I cells by high mechanical power ventilation causes a massive release of extracellular ATP beyond the clearance capacity of the extracellular ATPases. When extracellular ATP reaches levels >100 μM, the ATP receptors of the AT II cells become desensitized and surfactant impairment is initiated. The resulting alteration in viscoelastic properties and in alveolar opening and collapse time-constants leads to alveolar collapse and the redistribution of inspired air from the alveoli to the alveolar ducts, which become pathologically dilated. The collapsed alveoli connected to these dilated alveolar ducts are subject to a massive strain, exacerbating the ATP release. After reaching concentrations >300 μM extracellular ATP acts as a danger-associated molecular pattern, causing capillary leakage, alveolar space edema, and further deactivation of surfactant by serum proteins. Decreasing the tidal volume to 6 mL/kg or less at this stage cannot prevent further lung injury.

Indexed as

Adenosine TriphosphateAnimalsHumansLung InjuryPulmonary Surfactant-Associated ProteinsReceptors, Purinergic P2X4Receptors, Purinergic P2Y2Respiration, ArtificialSignal TransductionAdenosine TriphosphatePulmonary Surfactant-Associated ProteinsReceptors, Purinergic P2X4Receptors, Purinergic P2Y2extracellular ATPinnate immunityP2X receptorsP2Y receptorspurinergic signalingsurfactant dysfunctionventilation-induced lung injury

Identifiers

PMID29652806
PMCPMC5979391
OpenAlexW2796780384

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.